News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,106 Results
Type
Article (14251)
Company Profile (281)
Press Release (253574)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79534)
Career Advice (153)
Deals (13229)
Drug Delivery (35)
Drug Development (50470)
Employer Resources (31)
FDA (5725)
Job Trends (5134)
News (144449)
Policy (10034)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21675)
ALS (64)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (100)
Approvals (5755)
Artificial intelligence (123)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1477)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (117)
Cell therapy (329)
Cervical cancer (8)
Clinical research (41080)
Collaboration (542)
Compensation (258)
Complete response letters (13)
COVID-19 (1034)
CRISPR (41)
C-suite (163)
Cystic fibrosis (76)
Data (1520)
Denatured (11)
Depression (30)
Diabetes (137)
Diagnostics (1300)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29819)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48600)
Executive appointments (460)
FDA (6425)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (96)
Generative AI (10)
Gene therapy (252)
GLP-1 (365)
Government (1079)
Grass and pollen (2)
Guidances (21)
Healthcare (6594)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (91)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7274)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (208)
Leadership (3)
Legal (1386)
Liver cancer (33)
Lung cancer (205)
Lymphoma (101)
Machine learning (3)
Management (7)
Manufacturing (139)
MASH (53)
Medical device (2603)
Medtech (2604)
Mergers & acquisitions (6286)
Metabolic disorders (388)
Multiple sclerosis (54)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1263)
NextGen: Class of 2025 (2017)
Non-profit (853)
Northern California (1701)
Now hiring (22)
Obesity (193)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (128)
Patient recruitment (76)
Peanut (35)
People (25645)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14512)
Phase II (19106)
Phase III (12079)
Pipeline (805)
Policy (44)
Postmarket research (852)
Preclinical (6139)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1419)
Recruiting (12)
Regulatory (8642)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1486)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1974)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (8)
The Weekly (36)
United States (13220)
Vaccines (213)
Venture capitalists (32)
Weight loss (109)
Women's health (15)
Worklife (2)
Date
Today (116)
Last 7 days (502)
Last 30 days (1587)
Last 365 days (19611)
2025 (6220)
2024 (20561)
2023 (22420)
2022 (26834)
2021 (27810)
2020 (23359)
2019 (16224)
2018 (11738)
2017 (13751)
2016 (11845)
2015 (14351)
2014 (10395)
2013 (7486)
2012 (7532)
2011 (7616)
2010 (7430)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17327)
Australia (2935)
California (3849)
Canada (1142)
China (360)
Colorado (149)
Connecticut (151)
Delaware (102)
Europe (37247)
Florida (465)
Georgia (115)
Idaho (16)
Illinois (231)
India (10)
Indiana (91)
Iowa (2)
Japan (74)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (472)
Massachusetts (3068)
Michigan (70)
Minnesota (144)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (962)
New Mexico (12)
New York (1040)
North Carolina (551)
North Dakota (5)
Northern California (1701)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (738)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1486)
Tennessee (25)
Texas (447)
Utah (53)
Virginia (78)
Washington D.C. (30)
Washington State (351)
Wisconsin (15)
268,106 Results for "neurona therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline
April 4, 2025
·
4 min read
Press Releases
Neurona Therapeutics Presents Positive Clinical Data Update from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy at American Academy of Neurology Annual Meeting
April 8, 2025
·
6 min read
Biotech Bay
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for the potential treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s Co-Founder and Chief Executive Officer, is scheduled to host investor meetings at the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.
May 28, 2024
·
1 min read
Business
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment of Manher (AJ) Joshi, M.D., as Chief Medical Officer.
June 11, 2024
·
3 min read
Business
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment of Nadia Agopyan, Ph.D., RAC, as Senior Vice President of Regulatory Affairs.
June 26, 2024
·
4 min read
Press Releases
Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
February 20, 2025
·
4 min read
Biotech Bay
Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days
Neurona Therapeutics today announced that Cory R. Nicholas, Ph.D., Neurona’s chief executive officer, will present a corporate update on Tuesday, March 19 at 5:00 pm ET and host one-on-one meetings during the Stifel 2024 Virtual CNS Days taking place on March 19-20, 2024.
March 12, 2024
·
1 min read
News
Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
September 27, 2024
·
1 min read
Biotech Bay
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the U.S Food and Drug Administration (FDA) has granted the company’s lead product candidate, NRTX-1001, the RMAT expedited program designation for drug-resistant mesial temporal lobe epilepsy (MTLE).
June 18, 2024
·
5 min read
Biotech Bay
Neurona Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Lifesciences Conference
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s chief executive officer, will provide a corporate update at the Oppenheimer 34th Annual Healthcare Lifesciences Conference on Wednesday, February 14 at 2:00 pm ET.
February 7, 2024
·
1 min read
1 of 26,811
Next
